Reproductive rights in the United States: acquiescence is not a strategy. Read more about Reproductive rights in the United States: acquiescence is not a strategy.
Author Correction: Systemic dysfunction and plasticity of the immune macroenvironment in cancer models. Read more about Author Correction: Systemic dysfunction and plasticity of the immune macroenvironment in cancer models.
Publisher Correction: Advancing T cell-based cancer therapy with single-cell technologies. Read more about Publisher Correction: Advancing T cell-based cancer therapy with single-cell technologies.
Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis. Read more about Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis.
To do no harm - and the most good - with AI in health care. Read more about To do no harm - and the most good - with AI in health care.
Author Correction: Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression. Read more about Author Correction: Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression.
Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial. Read more about Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial.
Author Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis. Read more about Author Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis.
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial. Read more about The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. Read more about Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.
